Why is Biogen Pharma falling/rising?

As of 22-Sep, Biogen Pharmachem Industries Ltd is currently priced at 0.90, showing no change (0.00%). The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. In terms of performance, the stock has seen a 1.12% increase over the past week, but it has declined by 1.10% over the past month and is down 23.73% year-to-date. Despite these declines, there has been a notable increase in investor participation, with delivery volume rising by 36.22% against the 5-day average, suggesting some renewed interest. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader market context shows that while Biogen Pharma has performed positively over the past week, it has underperformed compared to the Sensex, which increased by 0.46% during the same period. Over the longer term, the stock has significantly lagged behind the benchmark, with a year-to-date decline of 23.73% compared to the Sensex's gain of 5.15%. This disparity highlights the challenges Biogen Pharma faces in the current market environment, despite some short-term positive indicators such as increased trading volume.